IH
BIIB icon

IFC Holdings’s Biogen BIIB Stock Holding History

IFC Holdings’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-4,050
Closed -$1.29M – 32
2017
Q4 		$1.29M Buy
4,050
+160
+4% +$51.3K 0.09% 159
2017
Q3 		$1.22M Buy
+3,890
New +$1.15M 0.08% 166
2017
Q2 		– Sell
-899
Closed -$245K – 495
2017
Q1 		$245K Buy
+899
New +$254K 0.02% 393
2016
Q1 		– Sell
-2,021
Closed -$620K – 394
2015
Q4 		$620K Buy
2,021
+41
+2% +$11.8K 0.08% 178
2015
Q3 		$565K Sell
1,980
-181
-8% -$59.8K 0.09% 167
2015
Q2 		$883K Buy
2,161
+313
+17% +$126K 0.13% 141
2015
Q1 		$792K Buy
1,848
+511
+38% +$201K 0.12% 146
2014
Q4 		$458K Buy
1,337
+266
+25% +$86.1K 0.08% 206
2014
Q3 		$354K Buy
1,071
+30
+3% +$9.89K 0.06% 231
2014
Q2 		$331K Buy
1,041
+23
+2% +$6.92K 0.06% 242
2014
Q1 		$301K Hold
1,018
– – 0.06% 236
2013
Q4 		$282K Buy
+1,018
New +$263K 0.06% 262
2013
Q3 		– Sell
-1,758
Closed -$378K – 348
2013
Q2 		$378K Buy
+1,758
New +$376K 0.09% 220

Other funds holding BIIB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

IFC Holdings's BIIB Position: Q1 2018 in Review

IFC Holdings sold out of Biogen (BIIB) in Q1 2018, closing a stake of 4,050 shares — an estimated $1.29M sold.

IFC Holdings first reported a position in BIIB in Q2 2013 and held it in 13 quarters. The position peaked at $1.29M in Q4 2017. 1,102 funds tracked by Wall St. Rank hold BIIB as of Q1 2018.

  • IFC Holdings reported no remaining Biogen position as of Q1 2018 after selling out during the quarter.
  • IFC Holdings sold 4,050 Biogen shares in Q1 2018, an estimated $1.29M.
  • IFC Holdings first reported a position in Biogen in Q2 2013 and held it in 13 quarters.
  • IFC Holdings's Biogen position peaked at $1.29M in Q4 2017.
  • 1,102 funds tracked by Wall St. Rank held Biogen as of Q1 2018.

Based on IFC Holdings's 13F filing for Q1 2018.